Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Submitted by
admin
on May 3, 2017 - 10:05am
Source:
Endpoints
News Tags:
Novartis
CAR-T
cell therapy
Celyad
Headline:
Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Do Not Allow Advertisers to Use My Personal information